Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Mesters

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|October 1, 1994
Cytokine response to infection in patients with acute myelogenous leukaemia following intensive chemotherapyH Ostermann, M Rothenburger, R M Mesters, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1995
Markers of coagulation activation for evaluation of the antithrombotic efficacy of heparin: a prospective study in acute deep venous thrombosisR M Mesters, T Mikoteit, M Schiller, et al.
The Journal of Biological Chemistry|February 5, 1993
Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein CM J Heeb, R M Mesters, G Tans, et al.
Blood|August 1, 1996
Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patientsR M Mesters, P M Mannucci, R Coppola, et al.
European Journal of Haematology|April 9, 2005
Stable remission after administration of rituximab in a patient with primary hepatic marginal zone B-cell lymphomaH R Gockel, J Heidemann, A Lugering, et al.
Cardiovascular Research|February 12, 1998
Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explantsT Padró, M Steins, C X Li, et al.
Annals of Hematology|March 4, 2003
Matrix metalloproteinase/integrin interactions as target for anti-angiogenic treatment strategiesT A Kessler, A Pfeifer, S Silletti, et al.
Leukemia & Lymphoma|October 21, 2003
Thalidomide for the treatment of acute myeloid leukemiaM B Steins, R Bieker, T Padró, et al.
Leukemia|September 23, 2006
Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemiaM Kreuter, K Woelke, R Bieker, et al.
Onkologie|October 16, 2001
[Angiogenesis in patients with hematologic malignancies]R M Mesters, T Padró, M Steins, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|October 1, 1994
Cytokine response to infection in patients with acute myelogenous leukaemia following intensive chemotherapyH Ostermann, M Rothenburger, R M Mesters, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1995
Markers of coagulation activation for evaluation of the antithrombotic efficacy of heparin: a prospective study in acute deep venous thrombosisR M Mesters, T Mikoteit, M Schiller, et al.
The Journal of Biological Chemistry|February 5, 1993
Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein CM J Heeb, R M Mesters, G Tans, et al.
Blood|August 1, 1996
Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patientsR M Mesters, P M Mannucci, R Coppola, et al.
European Journal of Haematology|April 9, 2005
Stable remission after administration of rituximab in a patient with primary hepatic marginal zone B-cell lymphomaH R Gockel, J Heidemann, A Lugering, et al.
Cardiovascular Research|February 12, 1998
Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explantsT Padró, M Steins, C X Li, et al.
Annals of Hematology|March 4, 2003
Matrix metalloproteinase/integrin interactions as target for anti-angiogenic treatment strategiesT A Kessler, A Pfeifer, S Silletti, et al.
Leukemia & Lymphoma|October 21, 2003
Thalidomide for the treatment of acute myeloid leukemiaM B Steins, R Bieker, T Padró, et al.
Leukemia|September 23, 2006
Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemiaM Kreuter, K Woelke, R Bieker, et al.
Onkologie|October 16, 2001
[Angiogenesis in patients with hematologic malignancies]R M Mesters, T Padró, M Steins, et al.
Pageof 5